Lord, Abbett & Co’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-58,620
Closed -$4M 539
2023
Q3
$4M Sell
58,620
-1,936
-3% -$164K 0.01% 488
2023
Q2
$5.69M Buy
+60,556
New +$4.72M 0.02% 465
2019
Q3
Sell
-435,728
Closed -$51.4M 728
2019
Q2
$51.4M Buy
435,728
+14,188
+3% +$1.43M 0.17% 213
2019
Q1
$36.5M Buy
+421,540
New +$35.9M 0.12% 269
2018
Q3
Sell
-1,173,304
Closed -$70.2M 841
2018
Q2
$70.2M Buy
1,173,304
+888,841
+312% +$47.8M 0.21% 148
2018
Q1
$11.5M Sell
284,463
-317,843
-53% -$15.5M 0.03% 598
2017
Q4
$31.6M Sell
602,306
-903,317
-60% -$48.2M 0.09% 349
2017
Q3
$70.9M Sell
1,505,623
-851,083
-36% -$34.3M 0.21% 138
2017
Q2
$83.4M Buy
2,356,706
+875,527
+59% +$27M 0.25% 114
2017
Q1
$35M Buy
1,481,179
+955,104
+182% +$18.9M 0.1% 303
2016
Q4
$7.03M Sell
526,075
-1,764,739
-77% -$28.5M 0.02% 661
2016
Q3
$42.5M Buy
2,290,814
+1,936,432
+546% +$34.1M 0.13% 250
2016
Q2
$4.34M Buy
+354,382
New +$2.67M 0.01% 740
2015
Q1
Sell
-954,841
Closed -$26.2M 917
2014
Q4
$26.2M Buy
+954,841
New +$23.2M 0.07% 408

Other funds holding EXAS

Lord, Abbett & Co's EXAS Position: Q4 2023 in Review

Lord, Abbett & Co sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 58,620 shares — an estimated $4M sold.

Lord, Abbett & Co first reported a position in EXAS in Q4 2014 and held it in 14 quarters. The position peaked at $83.4M in Q2 2017. 648 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

  • Lord, Abbett & Co reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
  • Lord, Abbett & Co sold 58,620 Exact Sciences shares in Q4 2023, an estimated $4M.
  • Lord, Abbett & Co first reported a position in Exact Sciences in Q4 2014 and held it in 14 quarters.
  • Lord, Abbett & Co's Exact Sciences position peaked at $83.4M in Q2 2017.
  • 648 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Lord, Abbett & Co's 13F filing for Q4 2023, filed 12 Feb 2024.